Stock VCEL VERICEL CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Vericel Corporation

Equities

VCEL

US92346J1088

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
46.05 USD +1.32% Intraday chart for Vericel Corporation +5.28% +29.32%
Apr. 19 Vericel Insider Sold Shares Worth $1,593,550, According to a Recent SEC Filing MT
Mar. 15 Vericel Insider Sold Shares Worth $1,552,075, According to a Recent SEC Filing MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Vericel Insider Sold Shares Worth $1,593,550, According to a Recent SEC Filing
Vericel Insider Sold Shares Worth $1,552,075, According to a Recent SEC Filing
Vericel Insider Sold Shares Worth $352,047, According to a Recent SEC Filing
Vericel Insider Sold Shares Worth $367,853, According to a Recent SEC Filing
Vericel Q4 EPS, Revenue Increase; Issues 2024 Outlook -- Shares Rise Pre-Bell
Vericel Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
Vericel Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Vericel Corporation Provides Earnings Guidance for the Fiscal Year 2024
Vericel Insider Sold Shares Worth $1,677,200, According to a Recent SEC Filing
Vericel Insider Sold Shares Worth $334,775, According to a Recent SEC Filing
Vericel Insider Sold Shares Worth $1,280,375, According to a Recent SEC Filing
Vericel Corporation Provides Earnings Guidance for the Year 2024
Vericel Reports Q4 Preliminary Unaudited Revenue; Shares Rise
Vericel Corporation Provides Earnings Guidance for the Fourth Quarter and Full-Year 2023
Vericel Insider Sold Shares Worth $853,800, According to a Recent SEC Filing
Vericel Insider Sold Shares Worth $832,909, According to a Recent SEC Filing
Vericel Insider Sold Shares Worth $617,798, According to a Recent SEC Filing
Vericel Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Vericel Corporation Provides Total Net Revenue Guidance for 2023
Vericel Corporation Announces U.S. Commercial Availability of NexoBrid (Anacaulase-Bbb) for the Treatment of Severe Thermal Burns in Adults
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VCEL Stock
  4. News Vericel Corporation
  5. Other languages